Shilpa Medicare News and Updates

Keep track of all breaking news on Shilpa Medicare from all sources in a single place.

Load latest

Shilpa Medicare Ltd.

14 Nov 2024

333.45

-0.45%

Shilpa Medicare shares climb 8% after multifold profit growth in Q2FY25

Business Standard

Shilpa Medicare's shares surged as much as 8.45 per cent to hit an intraday high of Rs 894.50 per share

Shilpa Medicare Ltd. is trading below all available SMAs

Shilpa Medicare Ltd.

16 Oct 2024

333.45

-0.45%

Shilpa Medicare's US Customer Gets Fast Track Approval For Glioblastoma Drug

NDTV Profit

Shilpa Medicare's drug is presently undergoing a Phase 1A clinical trial to test its safety and how well it is tolerated in various solid tumors, including GBM.

Shilpa Medicare Ltd. is trading below all available SMAs

Shilpa Medicare Ltd.

04 Oct 2024, 10:19AM

333.45

-0.45%

Shilpa Medicare shares rise 3% on receiving CEP for Desmopressin; details

Business Standard

Shilpa Medicare share price surged after the company said that its arm, Shilpa Pharma Lifesciences, has received certificate of suitability (CEP) from EDQM for API, Desmopressin

Shilpa Medicare has lost -25.13% in the last 1 Year

Shilpa Medicare Ltd.

16 Sep 2024

333.45

-0.45%

This pharma stock has zoomed 179% so far in CY24; Antique sees more upside

Business Standard

Shares of Shilpa Medicare hit a new high of Rs 922, gaining 4% in Monday's intra-day trade after Antique Stock Broking initiate coverage on the stock with a BUY rating and a target price of Rs 1,300.

Shilpa Medicare has lost -21.02% in the last 3 Months

Shilpa Medicare Ltd.

27 Aug 2024

333.45

-0.45%

Shilpa Medicare Gets FDA Approval For Bortezomib Injection

NDTV Profit

This is the first 'liquid' injection for Bortezomib, approved for both subcutaneous and intravenous administration by the FDA, the pharmaceutical firm says.

Shilpa Medicare Ltd. is trading below all available SMAs

Shilpa Medicare Ltd.

07 Aug 2024

333.45

-0.45%

Shilpa Medicare's stock rallies 8% on successful phase-1 trials of rHA

Business Standard

Shares of Shilpa Medicare soared up to 7.96 per cent at Rs 718.90 per share on the BSE in Wednesday's intraday deals

Shilpa Medicare has lost -23.77% in the last 6 Months

Shilpa Medicare Ltd.

08 Jul 2024

333.45

-0.45%

Shilpa Medicare Business Update Call

Conference Call with Shilpa Medicare Management and Analysts to discuss updates on CDMO business. Listen to the full transcript.

audio

Shilpa Medicare Ltd.

05 Jul 2024

333.45

-0.45%

This pharma stock has surged 16% on Friday; zoomed over 100% so far in CY24

Business Standard

Shilpa Medicare hit a multi-year high of Rs 672.50, rallied 16% after the company's CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order.